Table 2.

Characteristics of hearing loss observed in patients with cCMV-related SNHL (Group 1).

Case	NBHS	Sex	Laterality	Severity	Onset	Initial ABR (dB)	Follow-up ABR or Audio (dB)	OAE	Progression	Antiviral therapy	Preterm birth
1-1	Refer	M	Bilateral	Severe	Cong.	B)NR	B)40	Abnl.	Improved	Done	Yes
1-2	N/A	M	Bilateral	Mild	Unclear	B)30		Abnl.	N/A	Done	Yes
1-3	Refer	M	Bilateral	Severe	Cong.	R)NR, L)70		Abnl.	N/A	Not done	No
1-4	Pass	M	Unilateral	Mild	2 mo.	R)25, L)35	R)15, L)12	Abnl.	Improved	Done	No
1-5	Pass	F	Bilateral	Moderate	7 mo.	R)55, L)30	B)35	Abnl.	Improved	Done	No
1-6	Refer	F	Unilateral	Severe	Cong.	R)25, L)NR	R)25, L)NR	Abnl.	No change	Done	No
1-7	Refer	M	Unilateral	Severe	Cong.	R)NR, L)20	R)NR, L)20	Abnl.	No change	Done	No
1-8	Refer	F	Bilateral	N/A	Cong.	N/A		N/A	N/A	Done	No

Abnl: abnormal; Cong.: congenital; NR: no response; mo.: month-old; N/A: not available